17 alpha-hydroxylation deficiency.

Area of Science:

• Endocrinology
• Pediatric Endocrinology
• Reproductive Endocrinology

Background:

• Disorders of sexual development and hypertension can present similarly in pediatric patients.
• Distinguishing between various endocrine disorders is crucial for accurate diagnosis and management.
• 17 alpha-hydroxylase deficiency (17 alpha-OHD) is a specific form of congenital adrenal hyperplasia with unique clinical features.

Purpose of the Study:

• To differentiate 17 alpha-OHD from other conditions causing sexual immaturity and/or hypertension.
• To highlight the key diagnostic indicators for 17 alpha-OHD in female patients.
• To emphasize the utility of aldosterone measurement in diagnosing 17 alpha-OHD.

Main Methods:

• Comparative analysis of clinical presentations of 17 alpha-OHD with other disorders like androgen resistance, 5 alpha-reductase deficiency, and congenital adrenal hyperplasia (11 beta-OHD).
• Review of diagnostic criteria including sexual development, presence of hypertension, and electrolyte imbalances (hypokalemia).
• Emphasis on the diagnostic value of measuring aldosterone and deoxycorticosterone (DOC) levels.

Main Results:

• Conditions such as androgen resistance, 5 alpha-reductase deficiency, and gonadal dysgenesis do not present with hypertension, distinguishing them from 17 alpha-OHD.
• 11 beta-OHD, another form of congenital adrenal hyperplasia, causes pseudohermaphroditism and precocious puberty but differs from 17 alpha-OHD.
• Dexamethasone-suppressible hyperaldosteronism lacks sexual abnormalities.
• 17 alpha-OHD is strongly suspected in females with primary amenorrhea, hypertension, and hypokalemia.

Conclusions:

• 17 alpha-OHD can be reliably differentiated from other disorders of sexual development and hypertension.
• The combination of primary amenorrhea, hypertension, and hypokalemia is highly suggestive of 17 alpha-OHD in females.
• Measuring aldosterone levels is a key and readily available diagnostic step for 17 alpha-OHD.